Trial Profile
Prevention of HBV Reinfection After Liver Transplantation Using Entecavir Monotherapy After Short-term HBIg Administration: A Pilot Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 13 Apr 2012 Planned end date changed from 1 Jan 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 19 Jan 2010 New trial record